90357-51-0: Bicalutamide Oxirane Impurity
It is an associate impurity Bicalutamide. Bicalutamide is used together with a luteinizing hormone-releasing hormone (LHRH) analog (eg, goserelin or leuprolide) to treat stage D2 metastatic prostate cancer (cancer that has spread) in men. Bicalutamide belongs to the group of medicines called antiandrogens. It works by blocking the effects of testosterone (a male hormone).
Additional information on CAS 90357-51-0
Catalogue No.
VE006823
CAS No.
90357-51-0
Molecular Formula
C12H9F3N2O2
Molecular Weight
270.21
Parent drug
Bicalutamide
IUPAC Name
N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyl-2-oxiranecarboxamide
Synonyms
N/A
References
“Sci-Hub, Structural Basis for Antagonism and Resistance of Bicalutamide in Prostate Cancer, 10.1073/Pnas.0500381102.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1073/pnas.0500381102.
Status
In-stock
